Fluopsin C for Treating Multidrug-Resistant Infections: Activity Against Clinically Important Strains and Efficacy Against Carbapenemase-Producing .

The increasing emergence of multidrug-resistant (MDR) organisms in hospital infections is causing a global public health crisis. The development of drugs with effective antibiotic action against such agents is of the highest priority. In the present study, the action of Fluopsin C against MDR clinical isolates was evaluated under and conditions.